期刊文献+

冠心病患者血清SF、β_2-m和CRP测定的临床意义 被引量:4

Clinical Significance of Determination of Changes of Serum SF,β_2-m and CRP Levels in Patients with Coronary Heart Diseases
下载PDF
导出
摘要 目的探讨冠心病患者血清铁蛋白(SF)、β2-微球蛋白(β2-m)和C-反应蛋白(CRP)水平的变化及意义。方法应用放免法和免疫比浊法测定42例冠心病患者血清SF、β2-m和CRP水平的变化,并以35名正常人作对照。结果冠心病患者血清SF、β2-m和CRP水平均非常显著地高于正常人组(P<0.01),且SF、β2-m和CRP水平呈明显正相关(r=0.6285、0.6018,P<0.01)。结论检测冠心病患者血清SF、β2-m和CRP水平的变化对了解病情、指导临床实践均具有重要的临床价值。 Objective To investigate the clinical significance of changes of serum SF, β2-m and CRP levels in patients with comary heart diseases. Methods Serum SF, β2-m levels were detected with RIA and CRP levels with immuno turbidity in 42 cases of coronary heart diseases and 35 controls. Results The levels of serum SF, 62 - m and CRP were significantly higher in the patients than those in coatrols ( P 〈 0.01 ). Serum SF, β2- m and CRP levels were mutually positively correlated ( r = 0. 6285,0. 6018,P 〈 0. 01 ). Conclusion Serum SF, β2-m and CRP levels were closely related to the diseases process of coronary heart diseases and were of prognostic values.
出处 《放射免疫学杂志》 CAS 2006年第6期484-485,共2页 Journal of Radioimmanology
关键词 冠心病 铁蛋白 Β2-微球蛋白 C-反应蛋白 coronary heart diseases, ferritin ( SF), β2- microglobulin( β2- m), C - reactive protein (CRP)
  • 相关文献

参考文献3

二级参考文献27

  • 1胡俊斌,魏文宁,丁桂芝,袁莉,刘仲萍.糖尿病患者凝血与纤溶状态初探[J].中华内分泌代谢杂志,1996,12(2):118-119. 被引量:32
  • 2Dover GJ, Vaffe D. Therapy for beta-thalassemia-aparadigm for the treatment of genetic disorders. N Eeng1 J Med. 1994, 331:609.
  • 3Ofivieri NF, Nathan DG, MBC Miffn J H, et al. Survival in mediclfy treated patients with homozygous beta-thalassemia. N Eng1 J Med. 1994, 331:574.
  • 4Poluru LR, Sana ZR, Samia S, et al. High percentage of patients with myelodysplastic syndromes(MDS) show mitochondrial DNA (mt-DNA) mutations. Blood. 2000, 96(suppl):1551.
  • 5Bayraktar Y, Koseoglu T, Temizer A, et al. Relationship between the serum alanine aminotransferase level at the end of interferon and histologic changes in wild-type and precore mutant hepatitis B virus infections. J Viral Hepatol. 1996, 3(3):137.
  • 6Martin VR, Nogueras F, Gonzalez A, et al. Response of chronic hepatitis C to interferon-alpha treatment and relationship with iron metabolison. Rev Espo Enferm Dig. 1997, 89(7):523.
  • 7Crandal N, Milonan, N. Galloe AM, et al. Distribution of liver haemosiderin iron in 187 patients with various types of hepatic desease. APMIS. 1996, 104:220.
  • 8Harrison H, Adams PC. Hemochromatosis common genes, uncommon illness. Can Fam Physician. 2002, 48(15):1326.
  • 9Sullivan JL. Iron and the sex difference in heart disease. Lancet. 1981,1:1293.
  • 10Salonen JT, Nyyssonen K, Korpela H, et al. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation. 1992, 86:803.

共引文献38

同被引文献31

引证文献4

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部